| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sarpogrelate | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
0.44 | investigational | inverse agonist,antagonist |
| sarpogrelate | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
0.44 | investigational | inverse agonist |
| sarpogrelate | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
0.44 | approved | unknown |
| sarpogrelate | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
0.44 | approved | antagonist |
| sarpogrelate | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
0.33 | investigational | antagonist |
| click here to return to the previous page | ||||||||